These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8408644

  • 1. Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts.
    Murphy WJ, Back TC, Conlon KC, Komschlies KL, Ortaldo JR, Sayers TJ, Wiltrout RH, Longo DL.
    J Clin Invest; 1993 Oct; 92(4):1918-24. PubMed ID: 8408644
    [Abstract] [Full Text] [Related]

  • 2. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency.
    Murphy WJ, Conlon KC, Sayers TJ, Wiltrout RH, Back TC, Ortaldo JR, Longo DL.
    J Immunol; 1993 Apr 15; 150(8 Pt 1):3634-42. PubMed ID: 8468492
    [Abstract] [Full Text] [Related]

  • 3. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
    Tatsumi T, Takehara T, Kanto T, Miyagi T, Kuzushita N, Sugimoto Y, Jinushi M, Kasahara A, Sasaki Y, Hori M, Hayashi N.
    Cancer Res; 2001 Oct 15; 61(20):7563-7. PubMed ID: 11606395
    [Abstract] [Full Text] [Related]

  • 4. Antitumor effects of recombinant human prolactin in human adenocarcinoma-bearing SCID mice with human NK cell xenograft.
    Zhang J, Sun R, Wei H, Tian Z.
    Int Immunopharmacol; 2005 Feb 15; 5(2):417-25. PubMed ID: 15652770
    [Abstract] [Full Text] [Related]

  • 5. Antitumor effects of a bispecific antibody targeting CA19-9 antigen and CD16.
    Garcia de Palazzo I, Holmes M, Gercel-Taylor C, Weiner LM.
    Cancer Res; 1992 Oct 15; 52(20):5713-9. PubMed ID: 1394194
    [Abstract] [Full Text] [Related]

  • 6. In vivo effects of recombinant human interleukin 6, alone or in combination with local irradiation, on tumor growth in Lewis lung carcinoma-bearing mice.
    Lu L, Shen RN, Broxmeyer HE.
    Int J Cell Cloning; 1991 Sep 15; 9(5):511-20. PubMed ID: 1955739
    [Abstract] [Full Text] [Related]

  • 7. Human CD4+ effector T cells mediate indirect interleukin-12- and interferon-gamma-dependent suppression of autologous HLA-negative lung tumor xenografts in severe combined immunodeficient mice.
    Egilmez NK, Hess SD, Chen FA, Takita H, Conway TF, Bankert RB.
    Cancer Res; 2002 May 01; 62(9):2611-7. PubMed ID: 11980657
    [Abstract] [Full Text] [Related]

  • 8. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E, Greco G, Garrone B, Baccarini S, Mauri C, Venditti M, Carlei D, Belardelli F.
    J Clin Invest; 1998 Jan 15; 101(2):429-41. PubMed ID: 9435316
    [Abstract] [Full Text] [Related]

  • 9. Antitumor efficacy of a human interleukin-12 expression plasmid demonstrated in a human peripheral blood leukocyte/human lung tumor xenograft SCID mouse model.
    Hess SD, Egilmez NK, Shiroko J, Bankert RB.
    Cancer Gene Ther; 2001 May 15; 8(5):371-7. PubMed ID: 11477457
    [Abstract] [Full Text] [Related]

  • 10. Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells.
    Tanaka H, Yoshizawa H, Yamaguchi Y, Ito K, Kagamu H, Suzuki E, Gejyo F, Hamada H, Arakawa M.
    J Immunol; 1999 Mar 15; 162(6):3574-82. PubMed ID: 10092816
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo.
    Whiteside TL, Sung MW, Nagashima S, Chikamatsu K, Okada K, Vujanovic NL.
    Clin Cancer Res; 1998 May 15; 4(5):1135-45. PubMed ID: 9607570
    [Abstract] [Full Text] [Related]

  • 13. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD.
    Clin Cancer Res; 2000 Jun 15; 6(6):2268-78. PubMed ID: 10873077
    [Abstract] [Full Text] [Related]

  • 14. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.
    Clin Cancer Res; 1998 Nov 15; 4(11):2859-68. PubMed ID: 9829753
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG, Younes E, Visscher D, Hamzavi F, Kim S, Lam JS, Montecillo EJ, Ali E, Pontes JE, Puri RK, Haas GP.
    Clin Cancer Res; 1997 Oct 15; 3(10):1799-806. PubMed ID: 9815566
    [Abstract] [Full Text] [Related]

  • 16. Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2.
    Roychowdhury S, May KF, Tzou KS, Lin T, Bhatt D, Freud AG, Guimond M, Ferketich AK, Liu Y, Caligiuri MA.
    Cancer Res; 2004 Nov 01; 64(21):8062-7. PubMed ID: 15520217
    [Abstract] [Full Text] [Related]

  • 17. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
    Asselin-Paturel C, Megherat S, Vergnon I, Echchakir H, Dorothée G, Blesson S, Gay F, Mami-Chouaib F, Chouaib S.
    Cancer; 2001 Jan 01; 91(1):113-22. PubMed ID: 11148567
    [Abstract] [Full Text] [Related]

  • 18. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-gamma: a role for intrinsic tumor immunogenicity and IL-15.
    Gri G, Chiodoni C, Gallo E, Stoppacciaro A, Liew FY, Colombo MP.
    Cancer Res; 2002 Aug 01; 62(15):4390-7. PubMed ID: 12154045
    [Abstract] [Full Text] [Related]

  • 19. Adoptive cellular immunotherapy of human ovarian carcinoma xenografts in nude mice.
    Ortaldo JR, Porter HR, Miller P, Stevenson HC, Ozols RF, Hamilton TC.
    Cancer Res; 1986 Sep 01; 46(9):4414-9. PubMed ID: 3089592
    [Abstract] [Full Text] [Related]

  • 20. Tumor growth suppression by a mouse/human chimeric anti-CEA antibody and lymphokine-activated killer cells in vitro and in SCID mouse xenograft model.
    Senba T, Kuroki M, Arakawa F, Yamamoto T, Kuwahara M, Haruno M, Ikeda S, Matsuoka Y.
    Anticancer Res; 1998 Sep 01; 18(1A):17-24. PubMed ID: 9568050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.